PRICE T ROWE ASSOCIATES INC /MD/ - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 63 filers reported holding TCR2 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$74
+51.0%
48,9000.0%0.00%
Q4 2022$49
-99.9%
48,900
+43.0%
0.00%
Q3 2022$62,000
-37.4%
34,2000.0%0.00%
Q2 2022$99,000
-2.9%
34,200
-7.0%
0.00%
Q1 2022$102,000
-39.6%
36,781
+1.4%
0.00%
Q4 2021$169,00036,2810.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders